It will be very interesting to see if we get any further updates on beginning of trials. Current situation from pre Xmas update seems to be that burns trial "first patient treatment anticipated Q1", which may well mean no results until Q2. IV sepsis trial " Patient screening to take place Q1" so that would seem to indicate no chance of even starting trial Q1. I suspect any covid results will not make a huge difference unless it somehow demonstrates a clear path to generating income short term, by which even short term would mean years away after phase 3 human trials I assume. Looks like my prediction for march 31st may have, been wildly optimistic. I had hoped the burns results would come out shortly as they had described it as only 2 weeks trial previously, yet latest update only mentions first patient (singular?) treatment by end of quarter.
I guess they managed to raise cash at a great level and no particular rush from a company point of view now with plenty of cash in hand., as long as we don't burn too much cash in the meantime. Personally I think the way they have managed cash from listing to current point has been excellent so I don't think they would just throw it away now. Just frustrating watching the retrace after such a stellar rise.
RCE Price at posting:
$1.02 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)